NanoString Technologies
Agent46Agent Readiness: 46/100. Above median. Measured by StartupHub.ai. Median 41.Developer of spatial biology tools for life sciences research, now part of Bruker Spatial Biology.
About
NanoString Technologies was a biotechnology company focused on discovery and translational research, developing and marketing technologies for targeted detection of biological markers. Its platforms, including nCounter, GeoMx Digital Spatial Profiler, and CosMx Spatial Molecular Imager, enable scientists to explore gene expression and protein analysis in tissue samples. The company filed for Chapter 11 bankruptcy in February 2024 and its assets were acquired by Bruker Corporation in May 2024.
Key facts
At-a-glance profile data
- Website
- nanostring.com
- Headquarters
- Seattle, United States
- Founded
- 2003
- Employees
- 323
- Total funding
- $15M (Series E)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 4 Dec 2012 | Series E | $15M | - |
Tech stack
Detected on nanostring.com, last scanned 22 May 2026. Run your own scan
- Analytics
- Google Analytics 4, Google Tag Manager
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Hosting
- AWS
- Email provider
- Microsoft 365
Frequently asked
How much funding has NanoString Technologies raised?
NanoString Technologies has raised a total of $15M in funding. The most recent round on record is Series E.
How many employees does NanoString Technologies have?
NanoString Technologies has approximately 323 people on record.
What is NanoString Technologies's current status?
NanoString Technologies's current operating status is: Inactive.